News

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood. The findings of two new studies offer new opportunities to identify the children with the genetic risk for developing diabetes very early on.

According to a study, tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments.

Researchers describe the first system that enables two unrelated organisms to communicate.

In a study, P. aeruginosa worked with fluconazole to eliminate drug tolerance and clear a C. albicans infection.

Scientists have discovered a cellular mechanism that may yield insights into improving vaccines and better understanding cancer and autoimmune diseases.

Research suggests that the parasites that cause cutaneous leishmaniasis may have met their match in vaccines developed using CRISPR.

Researchers have formed lymphoid follicles in a microfluidic Organ Chip device that replicate human immune functions and vaccine responses in vitro.

A new testing mechanism that detects autoantibodies for phospholipids could diagnose Lyme disease earlier, help clinicians understand if treatments are working and identify patients who have been reinfected.

Trade-offs between the benefit of colonizing new particles and the risk of being wiped out by predators allow diverse populations of marine microbes to exist together, shows a new study.

With the help of two grants, a team of researchers is setting out to refine a cutting-edge breast cancer treatment known as viral mimicry.